iMagemHTT: FIH Evaluation of Novel Mutant Huntingtin PET Radioligands [¹¹C]CHDI-00485180-R and [¹¹C]CHDI-00485626

NCT03810898 · clinicaltrials.gov ↗
EARLY_PHASE1
Phase
TERMINATED
Status
24
Enrollment
OTHER
Sponsor class

Stopped Study terminated per protocol design post interim analysis review after Phase 2a. No SAEs or safety issues were noted.

Conditions

Interventions

Sponsor

CHDI Foundation, Inc.

Collaborators